MEDP vs QGEN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 27, 2026
MEDP
QGEN
Investment Advisor Scores
QGEN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MEDP | QGEN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 31.9489 | 13.5318 | QGEN |
| PEG Ratio | 2.9349 | 1.1661 | QGEN |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 17.2% | 0.3% | MEDP |
| Earnings Growth | 37.1% | 7.9% | MEDP |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 41.5/100 | 45.5/100 | QGEN |
| Profit Margin | 17.7% | 19.5% | QGEN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MEDP
NeutralMixed signals - no dominant trend phase, RSI 46
QGEN
MarkupPrice above SMA50, rising 50-day trend (3.0% over 20 days), RSI 55
Fundamentals Snapshot
| Metric | MEDP | QGEN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 31.0 | 17.1 |
| Trailing P/E | 35.1 | 22.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.2% | 0.3% |
| EPS | 17.04 | 1.89 |
| Dividend Yield | — | 0.01% |